Atomic Invest’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atomic Invest's BMY Position: Q2 2026 in Review
Atomic Invest reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, selling an estimated $3.96K and leaving 375 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #195.
Atomic Invest first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.5K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Atomic Invest held 375 shares of Bristol-Myers Squibb worth $22K as of Q2 2026.
- Atomic Invest sold 69 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.96K.
- Bristol-Myers Squibb made up ﹤0.01% of Atomic Invest's portfolio in Q2 2026, its #195 holding.
- Atomic Invest first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Atomic Invest's Bristol-Myers Squibb position peaked at $26.5K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Atomic Invest's 13F filing for Q2 2026, filed 25 Sep 2026.